Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting


Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first in class, allogeneic chimeric antigen receptor (CAR) and adaptor (CAd) gamma delta T cell therapies today announced four preclinical abstract poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting taking place November 8-12, 2022 in Boston, MA.

Poster Presentations:

Abstract Title: Innate-Enhanced Chimeric Adaptors (CAd): A Newly-Described Approach for Augmenting Potency of ?? T Cell Immunotherapy
Poster/Abstract Number: 198
Presenting Author: Marissa Herrman, Ph.D.
Date/Time: November 11, 2022 from 9:00am ? 9:00pm EST

Title: Preclinical Discovery and Characterization of Allogeneic anti-PSMA ?? CAR T Therapy for Prostate Cancer
Poster/Abstract Number: 203
Presenting Author: Nitya S. Ramadoss, Ph.D.
Date/Time: November 10, 2022 from 9:00am ? 9:00pm EST

Abstract Title: Allogeneic "off-the-shelf" ?? T cells modified with CD27- containing CAR for targeting CD70+ cancers
Poster/Abstract Number: 246
Presenting Author: Kevin P. Nishimoto, Ph.D.
Date/Time: November 11, 2022 from 9:00am ? 9:00pm EST

Abstract Title: Preclinical Discovery and Evaluation of Allogeneic "off-the-shelf" ?? CAR T Cells Targeting B7-H6+ Tumors
Poster/Abstract Number: 247
Presenting Author: Kevin P. Nishimoto, Ph.D.
Date/Time: November 10, 2022 from 9:00am ? 9:00pm EST

The abstracts will be available in a Journal for ImmunoTherapy of Cancer (JITC) supplement, which will be published on Monday, November 7 at 8:00am EST on www.sitcancer.org.

R&D Webcast

Adicet will host an R&D webcast presentation on Thursday, November 10, 2022 at 9:00am EST to provide an overview of its R&D pipeline.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic chimeric antigen receptor (CAR) and adaptor (CAd) gamma delta T cell therapies engineered to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.


These press releases may also interest you

at 15:16
CREDIT UNION OF SOUTHERN CALIFORNIA EARNS GALLUP 2024 EXCEPTIONAL WORKPLACE AWARD
Credit Union of Southern California (CU SoCal) was recognized by workplace consulting and research firm Gallup as one of the top 60 places to work worldwide by earning a Gallup Exceptional Workplace Award for 2024....

at 15:06
RedSense Announces Revolutionary Public Sector Safety Shield Solution
RedSense, a leader in Cyber Threat Intelligence, has launched its Public Sector Safety Shield Solution that enables state and regional cyber command centers to secure smaller public entities like municipalities, schools, and healthcare providers....

at 15:05
Scispot Announces Affordable Custom Lab Integration Solutions with Pay-As-You-Go Pricing
Scispot today unveiled its new custom lab integration solutions designed specifically for the evolving needs of biotech and pharma companies. These solutions now include a flexible pay-as-you-go pricing model, ensuring that labs only pay for the...

at 15:00
Parenteral Drug Association and Euromed Communications Release Second Co-published book, Industrial Pharmaceutical Microbiology: Quality Control
Parenteral Drug Association, Inc. (PDA) and UK-based Euromed Communications today announced the publication of Industrial Pharmaceutical Microbiology: Quality Control. This 500-page book includes 20 chapters from 19 industry leaders in pharmaceutical...

at 14:55
Businessabc.net, part of Ztudium group partners with IEBF to offer GenerativeAI tools for SMEs, Adds Dilip Pungliya to Leadership
Businessabc.net part of ztudium group partners with Indo-European Business Forum IEBF and signed an MOU to collaborate in building tech AI-powered tools and trade corridors and technological solutions for businesses in India, UK, and Europe....

at 14:52
Ontario One Call to support better locate performance as Administrative Penalty regulation comes into force May 1, 2024
Ontario One Call (OOC) is working closely with underground infrastructure owners/operators and excavators to usher in a new era of improved locate performance in the province of Ontario....

More news about Science and technology...


News published on and distributed by: